chr17-32488418-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_003885.3(CDK5R1):c.798C>T(p.Asn266Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000952 in 1,614,096 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0050 ( 5 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 6 hom. )
Consequence
CDK5R1
NM_003885.3 synonymous
NM_003885.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.918
Genes affected
CDK5R1 (HGNC:1775): (cyclin dependent kinase 5 regulatory subunit 1) The protein encoded by this gene (p35) is a neuron-specific activator of cyclin-dependent kinase 5 (CDK5); the activation of CDK5 is required for proper development of the central nervous system. The p35 form of this protein is proteolytically cleaved by calpain, generating a p25 form. The cleavage of p35 into p25 results in relocalization of the protein from the cell periphery to nuclear and perinuclear regions. P25 deregulates CDK5 activity by prolonging its activation and changing its cellular location. The p25 form accumulates in the brain neurons of patients with Alzheimer's disease. This accumulation correlates with an increase in CDK5 kinase activity, and may lead to aberrantly phosphorylated forms of the microtubule-associated protein tau, which contributes to Alzheimer's disease. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 17-32488418-C-T is Benign according to our data. Variant chr17-32488418-C-T is described in ClinVar as [Benign]. Clinvar id is 784742.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.918 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00503 (765/152210) while in subpopulation AFR AF = 0.0171 (708/41512). AF 95% confidence interval is 0.016. There are 5 homozygotes in GnomAd4. There are 383 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 765 AD gene.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDK5R1 | ENST00000313401.4 | c.798C>T | p.Asn266Asn | synonymous_variant | Exon 2 of 2 | 1 | NM_003885.3 | ENSP00000318486.3 | ||
CDK5R1 | ENST00000584716.1 | n.*116C>T | non_coding_transcript_exon_variant | Exon 2 of 3 | 1 | ENSP00000463654.1 | ||||
CDK5R1 | ENST00000584716.1 | n.*116C>T | 3_prime_UTR_variant | Exon 2 of 3 | 1 | ENSP00000463654.1 | ||||
CDK5R1 | ENST00000584792.5 | c.*116C>T | 3_prime_UTR_variant | Exon 2 of 2 | 2 | ENSP00000464129.1 |
Frequencies
GnomAD3 genomes AF: 0.00502 AC: 764AN: 152092Hom.: 5 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
764
AN:
152092
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00151 AC: 380AN: 251494 AF XY: 0.00115 show subpopulations
GnomAD2 exomes
AF:
AC:
380
AN:
251494
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000527 AC: 771AN: 1461886Hom.: 6 Cov.: 32 AF XY: 0.000480 AC XY: 349AN XY: 727244 show subpopulations
GnomAD4 exome
AF:
AC:
771
AN:
1461886
Hom.:
Cov.:
32
AF XY:
AC XY:
349
AN XY:
727244
Gnomad4 AFR exome
AF:
AC:
534
AN:
33480
Gnomad4 AMR exome
AF:
AC:
74
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26136
Gnomad4 EAS exome
AF:
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
AC:
6
AN:
86258
Gnomad4 FIN exome
AF:
AC:
0
AN:
53416
Gnomad4 NFE exome
AF:
AC:
62
AN:
1112010
Gnomad4 Remaining exome
AF:
AC:
83
AN:
60394
Heterozygous variant carriers
0
60
120
179
239
299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00503 AC: 765AN: 152210Hom.: 5 Cov.: 32 AF XY: 0.00515 AC XY: 383AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
765
AN:
152210
Hom.:
Cov.:
32
AF XY:
AC XY:
383
AN XY:
74440
Gnomad4 AFR
AF:
AC:
0.0170553
AN:
0.0170553
Gnomad4 AMR
AF:
AC:
0.00261814
AN:
0.00261814
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000147042
AN:
0.000147042
Gnomad4 OTH
AF:
AC:
0.00332068
AN:
0.00332068
Heterozygous variant carriers
0
34
68
102
136
170
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 13, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at